HydraDx

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

HydraDx - overview

Established

2008

Location

Pasadena, CA, US

Primary Industry

Biotechnology

About

HydraDx is a technology-driven company specializing in innovative solutions that optimize operational processes for various industries, enhancing efficiency and service delivery through advanced products. HydraDx, based in Pasadena, US, was founded in 2008 and focuses on developing technological solutions. The company has raised a total of USD 0. 13 mn across multiple funding rounds, with its most recent round being VENTURE DEBT in July 2011, securing USD 0.


52 mn. CEO Grant Donovan leads the company, which has completed five deals since its inception. HydraDx offers a diverse portfolio of innovative products and services aimed at addressing operational challenges for businesses. Their technological solutions improve efficiency, reduce costs, and enhance service delivery across various sectors.


The company serves clients in North America, Europe, and Asia, catering to both small and medium enterprises as well as larger corporations seeking to streamline their operations. The revenue model of HydraDx is based on direct sales of flagship products complemented by a subscription-based service for ongoing support and updates. Clients engage in a standard transaction for product procurement and subsequently subscribe annually for software maintenance and enhancements, ensuring recurring revenue and continuous value delivery. Pricing plans are customized to cater to the different needs of clients, balancing affordability with the premium nature of their trademarked offerings.


HydraDx plans to utilize the recent funding from their VENTURE DEBT round for further product development and market expansion. They are working on new products aimed at enhancing operational efficiencies, with specific release dates yet to be announced. The company is also targeting expansion into additional markets in Asia and Europe by the end of 2023, leveraging their technological advancements to cater to a broader clientele.


Current Investors

Arcturus Capital, Frontier Venture Capital

Primary Industry

Biotechnology

Sub Industries

Biotechnology

Website

www.hydradx.com

Verticals

HealthTech

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.